AQR Capital Management - IDERA PHARMACEUTICALS INC ownership

Quarter-by-quarter ownership
AQR Capital Management ownership history of IDERA PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2018$32,000
-90.4%
17,631
-88.8%
0.00%
Q4 2017$334,000
+227.5%
158,091
+378.5%
0.00%
Q4 2015$102,000
-44.9%
33,039
-40.1%
0.00%
Q3 2015$185,000
-94.0%
55,122
-93.3%
0.00%
-100.0%
Q2 2015$3,076,000
+14.6%
828,880
+14.5%
0.01%0.0%
Q1 2015$2,685,000
+19.8%
723,721
+42.3%
0.01%
+20.0%
Q4 2014$2,242,000
+17.3%
508,436
-39.1%
0.01%0.0%
Q3 2014$1,912,000
+357.4%
835,115
+479.1%
0.01%
+400.0%
Q2 2014$418,000
-26.5%
144,215
+3.4%
0.00%
-50.0%
Q1 2014$569,000
-11.8%
139,4150.0%0.00%0.0%
Q4 2013$645,000
+65.0%
139,415
-38.0%
0.00%
+100.0%
Q3 2013$391,000225,0000.00%
Other shareholders
IDERA PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Broadfin Capital, LLC 3,094,745$9,563,0000.59%
WALL STREET ASSOCIATES 400,000$1,236,0000.35%
Palo Alto Investors LP 1,257,748$3,886,0000.22%
Baker Brothers Advisors 6,983,107$21,578,0000.18%
NATIXIS 3,148,916$9,730,0000.16%
GUARDIAN LIFE INSURANCE CO OF AMERICA 371,759$1,149,0000.12%
MYCIO WEALTH PARTNERS, LLC 200,000$618,0000.11%
HOLLENCREST CAPITAL MANAGEMENT 177,570$549,0000.10%
DRIEHAUS CAPITAL MANAGEMENT LLC 701,815$2,169,0000.07%
CARL DOMINO INC 29,137$90,0000.07%
View complete list of IDERA PHARMACEUTICALS INC shareholders